Ami J Claxton
Overview
Explore the profile of Ami J Claxton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
92
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Feldman S, Guerin A, Gauthier-Loiselle M, Claxton A, Hazra N, Meng Y, et al.
J Dermatolog Treat
. 2024 May;
35(1):2345739.
PMID: 38705585
Evidence on treatment preferences of patients with moderate-to-severe atopic dermatitis (AD) in the United States (US) is limited and an assessment of treatment preferences in this group is warranted. An...
2.
Claxton A, Thompson-Leduc P, Kirson N, Rice B, Hey J, Iankova I, et al.
Crit Care Med
. 2018 Aug;
46(9):1560.
PMID: 30113378
No abstract available.
3.
Brunelli S, Blanchette C, Claxton A, Roy D, Rossetti S, Gutierrez B
Clinicoecon Outcomes Res
. 2015 Jan;
7:65-72.
PMID: 25609987
Background: Autosomal dominant polycystic kidney disease (ADPKD) is the leading inheritable cause of end-stage renal disease (ESRD) and one of the leading causes of ESRD overall. ADPKD patients differ from...
4.
Ramakrishnan K, Braunhofer P, Newsome B, Lubeck D, Wang S, Deuson J, et al.
Adv Ther
. 2014 Dec;
31(12):1272-86.
PMID: 25479935
Introduction: Hyperphosphatemia (serum phosphorus >5.5 mg/dL) in hemodialysis patients is a key factor in mineral and bone disorders and is associated with increased hospitalization and mortality risks. Treatment with oral...
5.
Robinson R, Birnbaum H, Morley M, Sisitsky T, Greenberg P, Claxton A
J Rheumatol
. 2003 Jun;
30(6):1318-25.
PMID: 12784409
Objective: Fibromyalgia (FM) is characterized by widespread pain that can lead to significant patient disability, complex management decisions for physicians, and economic burden on society. We investigated the total costs...
6.
Corey-Lisle P, Birnbaum H, Greenberg P, Marynchenko M, Claxton A
J Clin Psychiatry
. 2002 Aug;
63(8):717-26.
PMID: 12197453
Background: Major depressive disorder (MDD) is a debilitating condition with significant economic consequences. Conservative estimates indicate that between 10% and 20% of all individuals with MDD are treatment resistant. The...